MC
Mool Chand Namdev
About Mool Chand Namdev
Data last updated:
Mool Chand Namdev is a Director at Nuken Pharmaceuticals Private Limited (since 2016). The companies operate in Non-Profit Organizations. Earlier, Mool Chand Namdev was a Director at Oaken Medicines Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 May 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jul 2014 | 2014 | ₹8.1 Lakh (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mool Chand Namdev
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chetan Kumar | 07458225 | Nuken Pharmaceuticals Private Limited | Director |
| Deepa Pachoria | 07458215 | Nuken Pharmaceuticals Private Limited | Director |
| Suman Pachoria | 07458238 | Nuken Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mool Chand Namdev
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mool Chand Namdev
Mool Chand Namdev currently holds 1 directorship: Nuken Pharmaceuticals Private Limited (Director, since 31 May 2016).
Mool Chand Namdev was first appointed on 25 Jul 2014 as Director at Oaken Medicines Private Limited. The most recent appointment on record is 31 May 2016 at Nuken Pharmaceuticals Private Limited.
Mool Chand Namdev held 1 earlier board appointment: Oaken Medicines Private Limited (Director, from 25 Jul 2014).
The current boards of Mool Chand Namdev's companies include Chetan Kumar (Nuken Pharmaceuticals Private Limited), Deepa Pachoria (Nuken Pharmaceuticals Private Limited), Suman Pachoria (Nuken Pharmaceuticals Private Limited).